Rectal Prolapse News and Research

RSS

Vaginal birth after previous cesarean section linked with higher risk of pelvic floor surgery

Vaginal birth after a previous cesarean section is associated with an increased risk of pelvic floor surgery compared with planning another cesarean, according to research publishing November 22nd in the open access journal PLOS Medicine.

23 Nov 2022

Embarrassing symptoms prevent women from seeking treatment for pelvic floor disorders

Nearly 25% of women live with treatable conditions known as pelvic floor disorders, but there is one main reason why the vast majority of them will not seek treatment: they are too embarrassed to talk about it.

20 Nov 2019

NAFC designates Beth Israel Deaconess Medical Center as Center of Excellence

The National Association For Continence has designated Beth Israel Deaconess Medical Center as a Center of Excellence: Continence Care. Anurag K. Das, MD; Roger Lefevre, MD; Janet Li, MD; and Deborah A. Nagle, MD are the principle physicians for this COE.

27 Feb 2014

Fecal incontinence remains a problem after laparoscopic surgery

Fecal incontinence improves after surgery for rectal prolapse, but research shows that the degree of improvement is quite low.

19 Sep 2012

Ventral rectoplexy helps recover sexual function

Laparoscopic ventral rectoplexy may reduce sexual dysfunction in women with complex posterior floor prolapse, say researchers who found many patients appreciated having postoperative investigation of their symptoms.

13 Jun 2012

Salix enters definitive agreement to acquire Oceana Therapeutics

Salix Pharmaceuticals, Ltd. and Oceana Therapeutics, LLC today announced that they have entered into a definitive agreement whereby Salix will acquire all of the outstanding stock of Oceana Therapeutics, Inc., a privately-held global provider of gastroenterology and urology therapeutics, for $300 million in cash.

8 Nov 2011

Oceana Therapeutics receives FDA approval for Solesta injectable gel to treat fecal incontinence

The U.S. Food and Drug Administration today approved a sterile, injectable gel to treat fecal incontinence in patients for whom other therapies such as diet change, fiber therapy or anti-motility medications failed.

30 May 2011